At Exogenus Therapeutics, we strive to address unmet needs in the fields of regenerative medicine and inflammatory disorders.

Exo-101, our lead candidate, has been shown in vitro and in vivo to have regenerative, anti‑inflammatory and immunomodulatory properties. 

Inflammatory skin conditions:

Due to its immunomodulatory properties, Exo-101 is being explored for inflammatory skin diseases, such as psoriasis.

Inflammatory lung disorders:

The combination of pro-regenerative and anti-inflammatory potential of Exo-101 may benefit patients with inflammatory lung diseases, including COVID-19-related respiratory complications.

Chronic wounds:

Exo-101 has been shown to accelerate the healing of chronic wounds.